New Jersey · 2026-2027 Regular Session · Bill

A 5359: Classifies 7 Hydroxymitragynine as Schedule I drug.

In committee Last action September 10, 2026: Introduced, Referred to Assembly Judiciary Committee

Plain-language summary

A 5359 is a bill introduced in the New Jersey House on September 10, 2026. According to its official title, it concerns: Classifies 7 Hydroxymitragynine as Schedule I drug. Primary sponsor: Mike Inganamort (Republican), Clinton Calabrese (Democratic), Cody Miller (Democratic). It lists 1 additional sponsor. Most recent recorded action (September 10, 2026): Introduced, Referred to Assembly Judiciary Committee.

Sponsors

Primary sponsors: Mike Inganamort (Republican); Clinton Calabrese (Democratic); Cody Miller (Democratic). 1 co-sponsor.